In the current issue of Journal of Lipid Research, Shao et al. (11) provide further evidence for the potential of SP-B as an HDL-associated biomarker, namely for risk of ASCVD in patients with diabetes mellitus type 1. This evidence concerns the gene SFTPB and diabetes mellitus.